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Background: The development of pain after peripheral nerve and tissue injury involves not only neuronal
pathways but also immune cells and glia. Central sensitization is thought to be a mechanism for such persistent
pain, and ATP involves in the process. We examined the contribution of glia to neuronal excitation in the juvenile
rat spinal dorsal horn which is subjected to neuropathic and inflammatory pain.
Results: In rats subjected to neuropathic pain, immunoreactivity for the microglial marker OX42 was markedly
increased. In contrast, in rats subjected to inflammatory pain, immunoreactivity for the astrocyte marker glial
fibrillary acidic protein was increased slightly. Optically-recorded neuronal excitation induced by single-pulse
stimulation to the dorsal root was augmented in rats subjected to neuropathic and inflammatory pain compared to
control rats. The bath application of a glial inhibitor minocycline and a p38 mitogen-activated protein kinase
inhibitor SB203580 inhibited the neuronal excitation in rats subjected to neuropathic pain. A specific P2X1,2,3,4
antagonist TNP-ATP largely inhibited the neuronal excitation only in rats subjected to neuropathic pain rats. In
contrast, an astroglial toxin L-alpha-aminoadipate, a gap junction blocker carbenoxolone and c-Jun N-terminal
kinase inhibitor SP600125 inhibited the neuronal excitation only in rats subjected to inflammatory pain. A greater
number of cells in spinal cord slices from rats subjected to neuropathic pain showed Ca2+ signaling in response to
puff application of ATP. This Ca2+ signaling was inhibited by minocycline and TNP-ATP.
Conclusions: These results directly support the notion that microglia is more involved in neuropathic pain and
astrocyte in inflammatory pain.
Keywords: Plasticity, Hyperalgesia, Optical imaging, Calcium imagingBackground
Persistent pain caused by peripheral nerve injury (neuro-
pathic pain) and peripheral tissue injury (inflammation)
increases the sensitivity to noxious stimuli (hyperalgesia)
and/or induces a pain sensation in response to light-touch
(allodynia). Central sensitization, which is an enhanced re-
sponsiveness of nociceptive neurons in the central ner-
vous system to their normal afferent input, is thought to
be a mechanism for hyperalgesia and allodynia [1,2].
In recent years, it is increasingly recognized that glial
cells in the spinal dorsal horn, such as microglia and
astrocytes, are activated in response to peripheral nerve* Correspondence: Emai:ikeda@synapse.his.u-fukui.ac.jp
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provided the original work is properly cited.injury and peripheral tissue injury and are involved in
spinal nociceptive transmission and central sensitization
[3-5]. Activation of glial cells has been shown to be dir-
ectly involved in neuropathic and inflammatory pain,
since blocking the activation of spinal cord microglia
with minocycline [6-8] and astrocytes with fluorocitrate
and L-alpha-aminoadipate [9,10] prevents or delays the
development of allodynia and hyperalgesia.
A number of mechanisms for the induction and main-
tenance of glia-related persistent pain have been sug-
gested. These include activation of mitogen-activated
protein kinases (MAPKs), such as the extracellular signal-
regulated kinases (ERKs) [11,12], p38 MAPK [13,14] and
c-Jun N-terminal kinases (JNK) [9,11,15], upregulated ex-
pression of P2 purinoceptors [16], and increased proin-
flammatory cytokines such as interleukin (IL)-1β, IL-6,icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
Figure 1 Mechanical allodynia produced by unilateral injection
of CFA or by PNI in rats. Mechanical allodynia produced by
unilateral injection of complete Freund adjuvant (CFA) or by
peripheral nerve injury (PNI) in rats. Rats were tested for mechanical
sensitivity of ipsilateral (ipsi) and contralateral (contra) hind paws 1
week after treatment. Data are expressed as mean withdrawal
threshold (g). *P< 0.05, **P< 0.01.
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chemokines such as CCL2 [18]. How these kinases and
purinergic receptors affect the electrophysiological activ-
ities in the spinal cords has also been reported [18,19].
The responsiveness of glial cells to ATP in neuropathic
pain condition is also revealed [14,19,20].
However, there is no direct evidence which compare the
amplitude of neuronal excitation and the effect of glia-
related agents on the excitation under persistent pain
induced by peripheral nerve and tissue injury with control,
untreated condition. The comparison of Ca2+ signal to
ATP stimulation in the spinal slices under the condition
of inflammatory or neuropathic pain with control condi-
tion is also not reported. The aim of this study is to reveal
whether or not the glia-related agents, which have been
used in various studies, are indeed affecting the neuronal
excitation recorded by optical method. More specifically,
we focus on whether microglia and astrocyte have differ-
ential roles in neuropathic pain and inflammatory pain.
We also like to study how ATP induces Ca2+ signals in the
superficial dorsal horn in slices obtained under neuro-
pathic and inflammatory conditions.
Results
Morphological changes of glial cells in the spinal dorsal
horn in response to inflammatory and neuropathic pain
To examine morphologic changes of glial cells during
pain hypersensitivity under condition of inflammatory
pain and neuropathic pain, we performed the immuno-
histochemical staining of glial cells. One week after uni-
lateral injection of CFA into the hind paw (used as a
model of inflammatory pain), the paw-withdrawal
threshold to mechanical stimulation was significantly
decreased in the ipsilateral and contralateral paw in
comparison to control, untreated rats (CFA: n = 16, con-
trol: n = 8, ipsilateral: P< 0.01, contralateral: P< 0.05)
(Figure 1). Quantification of immunoreactivity by meas-
uring the intensity of the staining revealed a significant
increase in GFAP immunoreactivity (astrocyte marker),
but not in OX 42 immunoreactivity (microglia marker),
in ipsilateral and contralateral superficial dorsal horn
(n = 16, GFAP: ipsilateral, 117 ± 5%, P< 0.05, contralat-
eral, 108 ± 3%, P = 0.1, OX42: ipsilateral, 103 ± 3%,
P = 0.9, contralateral, 102 ± 3%, P = 0.9) (Figure 2). The
immunoreactivity of GFAP and OX42 was not increased
in saline-injected rats (n = 3, GFAP: ipsilateral, 104 ± 5%,
P = 0.8, contralateral, 99 ± 1%, P = 0.9, OX42: ipsilateral,
97 ± 1%, P = 0.8, contralateral, 99 ± 2%, P = 0.9).
One week after unilateral PNI of the fifth lumber spinal
nerves (used as a model of neuropathic pain), the paw-
withdrawal threshold to the mechanical stimulation was
significantly decreased in the ipsilateral but not contralat-
eral paw (n= 6, ipsilateral: P< 0.01, contralateral: P = 0.6)
(Figure 1). Quantification of immunoreactivity revealed asignificant increase in OX 42 immunoreactivity, but not in
GFAP immunoreactivity, on the ipsilateral superficial dor-
sal horn, and there was no significant change in OX 42 or
GFAP immunoreactivity on the contralateral side (n= 14,
GFAP: ipsilateral, 109 ± 6%, P= 0.8, contralateral, 98 ± 4%,
P = 0.9, OX42: ipsilateral, 175 ± 5%, P< 0.01, contralateral,
104 ± 5%, P = 0.9) (Figure 2). The immunoreactivity of
GFAP and OX42 was not increased in sham-operated rats
(n= 4, GFAP: ipsilateral, 102 ± 4%, P= 0.9, contralateral,
101 ± 9%, P = 0.9, OX42: ipsilateral, 122 ± 10%, P= 0.2,
contralateral, 98 ± 4 %, P = 0.9).
Difference in optically-recorded neuronal excitation
evoked by dorsal root stimulation
We visualized gross neuronal excitation in the superficial
dorsal horn of transverse spinal cord slices stained with
the voltage-sensitive dye, RH-482 [21-23]. A single-pulse
stimulation of C fiber-activating strength to the dorsal
root evoked an optical response in spinal laminae I-III
Figure 2 Quantification of OX 42 and glial fibrillary acidic
protein (GFAP) immunofluorescence intensity. Quantification of
OX 42 and glial fibrillary acidic protein (GFAP) immunofluorescence
intensity in the ipsilateral (ipsi; white bars) and contralateral (contra;
black bars) spinal dorsal horn of rats injected with complete Freund
adjuvant (CFA) or rats subjected to peripheral nerve injury (PNI).
Data are expressed as % of mean intensity of OX 42 and GFAP
immunofluorescence in control, untreated rats. *P< 0.05, **P< 0.01.
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out the thickness of the slice. Neuronal excitation in the
ipsilateral spinal dorsal horn evoked by such stimulus
was augmented in CFA injected rats (174 ± 16%, n = 20,
P< 0.01) and in rats subjected to PNI (178 ± 14 %,
n = 10, P< 0.01) in comparison to control, untreated rats
(Figure 3B, C). There were no significant difference inoptically recorded neuronal excitation in slices obtained
from CFA injected rats and rats subjected to PNI
(P = 0.9). These augmentations of neuronal excitation in
CFA injected rats and rats subjected to PNI were
observed not only in L5 injured segment of spinal cord,
but also in neighboring uninjured segments (L4, L6).
The magnitude of A-fiber response induced by low-
intensity stimulation was usually 0.01% or less of the
background light intensity, close to the noise level of the
system [21]. Therefore, we did not examine optical
responses induced by low-intensity stimulation.
Contribution of microglia, purinoceptors and p38 MAPK
to hyperexcitability of the spinal dorsal horn by
neuropathic pain
It has been reported that the expression of the P2X4 re-
ceptor subtype of ionotropic purinoceptor and activation
of p38 MAPK increase in microglia, but not neurons or
astrocytes, in the ipsilateral spinal dorsal horn after PNI,
and that this increase parallels the increase in pain
hypersensitivity [12,14,17]. We therefore examined the
contributions of microglia, the P2X4 receptor, and p38
MAPK to the augmentation of neuronal excitation in
the superficial spinal dorsal horn of rats injected with
CFA and rats subjected to PNI.
Neuronal excitation in rats subjected to PNI was sig-
nificantly inhibited by the microglial inhibitor minocy-
cline (20 μM, 30 min) in comparison to control,
untreated rats (-32 ± 3%, n= 7, P< 0.01), whereas that in
rats injected with CFA was unaffected (-11 ± 2%, n = 6,
P = 0.7) (Figure 4A). Neuronal excitation in both group
of rats was not significantly inhibited by the specific
P2X1,2,3,5 antagonist pyridoxal-phosphate-6-azophenyl-
2',4'-disulfonate (PPADS) (20 μM, 30min) in comparison
to control rats (PNI: -17 ± 2%, n = 5, P = 0.1: CFA: -13 ±
5 %, n = 6, P = 0.5) (Figure 4B). However, neuronal exci-
tation in rats subjected to PNI was significantly inhibited
by a mixed solution of PPADS and the specific P2X1,2,3,4
antagonist 2',3'-O-(2,4,6-trinitrophenyl) adenosine 5'-tri-
phosphate (TNP-ATP) (1 μM, 30 min) after incubation
with PPADS alone (PNI: -23 ± 4%, n= 5, P< 0.01, CFA:
-6 ± 4%, n = 6, P = 0.3) (Figure 4C). Neuronal excitation
in rats subjected to PNI was also inhibited by p38
MAPK inhibitor SB203580 (1 μM, 30 min) (PNI: -30 ±
3%, n = 5, P< 0.01, CFA: -4 ± 6%, n= 3, P = 0.7)
(Figure 4D). These results indicate that hyperexcitability
in rats subjected to PNI are contributed by microglia
and P2X4 and p38 MAPK.
Contribution of JNK and gap junction in astrocyte to
hyperexcitability in the spinal dorsal horn by
inflammatory insult, but by nerve injury
Astrocytes in the spinal dorsal horn also play an import-
ant role in pain hypersensitivity. It has been reported
Figure 3 Neuronal excitation in the spinal cord slices. Neuronal
excitation in the spinal cord slices in control rats, rats injected with
complete Freund adjuvant (CFA), and rats subjected to peripheral
nerve injury (PNI). A, Schematic of a transverse spinal cord slice.
Images in B were obtained from the area indicated by the green
rectangle in A. B, Images in the left column are representative
examples of optical responses elicited by a single-pulse stimulation
to the dorsal root at the peak time point. The percent change in
light absorption is depicted by simulated color, as indicated by the
color bar. Graphs in the right column are representative examples of
time courses of optical responses. Each time course was indicate
examples of time courses of optical responses. Each time course was
an average of 128 optical responses recorded by 16 × 16 pixels on
the image sensor in the dorsal horn indicated by the black rectangle
in each image. Stimulus pulses were administered at the time
indicated by the filled triangle. C, Mean intensity of optical response.
The intensity of each response was obtained by temporal
integration of optical response magnitude during the 18-ms period
after the onset of response. Data are expressed as % of mean
intensity of optical response in control, untreated rats. *P< 0.05,
**P< 0.01.
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tributes to pain hypersensitivity [9,11,15,24]. We there-
fore examined the contribution of astrocytes, namely
whether or not JNK and gap junction contribute to the
augmentation of neuronal excitation in the superficial
spinal dorsal horn of rats injected with CFA and rats
subjected to PNI. Neuronal excitation in rats injected
with CFA, but not in rats subjected to PNI, was signifi-
cantly inhibited by the astroglial toxin L-alpha-
aminoadipate (L-α-AA, 1 mM, 20 min) (PNI: -10 ± 1%,
n = 5, P = 0.3, CFA: -25 ± 2 %, n = 4, P< 0.01), a gap
junction blocker carbenoxolone (100 μM, 20 min, PNI: -
10 ± 1%, n= 5, P = 0.9, CFA: -27 ± 5%, n = 4, P< 0.01)
and the JNK inhibitor SP600125 (10 μM, 30 min, PNI: -
3 ± 2%, n = 5, P = 1, CFA: -23 ± 3%, n= 10, P< 0.05) in
comparison to control rats (Figure 5).
Augmentation of ATP-induced Ca2+ signaling via P2X4
receptors in the spinal dorsal horn by nerve injury
Glial cells are not electrically activated and do not com-
municate directly via action potentials. However, they
display a form of excitability that is manifested by an in-
crease in intracellular Ca2+ concentration [25,26]. We
therefore visualized increases in intracellular Ca2+ by
Ca2+ imaging in the spinal cord slices.
A greater number of cells in the ipsilateral spinal dorsal
horn responded to puff -application of ATP (100 μM) with
increased Ca2+ signaling in rats subjected to PNI than in
control rats (25 ± 3 cells vs. 13 ± 1 cells, respectively,
n = 21, P< 0.01). This was not observed in rats injected
with CFA (18 ± 1 cells, n = 7, P= 0.09) (Figure 6A, B). A
microglial inhibitor minocycline (20 μM) and a specific
P2X1,2,3,4 antagonist TNP-ATP (1 μM), but not the astro-
glial toxin L-α-AA (1 mM) and a specific P2X1,2,3,5
Figure 4 Effect of microglial inhibitor, P2X receptor antagonists
and p38 MAPK inhibitor on neuronal excitation. Effect of the
microglial inhibitor minocycline (20 μM) (A), the specific P2X1,2,3,5
antagonist pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS,
20 μM) (B), the specific P2X1,2,3,4 antagonist 2',3'-O-(2,4,6-
trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP, 1 μM) (C) and
the p38 MAPK inhibitor SB203580 (1 μM) (D) on neuronal excitation
in control rats, rats injected with complete Freund adjuvant (CFA),
and rats subjected to peripheral nerve injury (PNI). Data are
expressed as % inhibition of the mean intensity of the optical
response during the preincubation period. *P< 0.05, **P< 0.01.
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responding to the ATP in rats subjected to PNI (minocy-
cline: -81 ± 3%, n= 5, P< 0.05, L-α-AA: -20 ± 10%, n= 3,
P = 0.3, PPADS: -23 ± 10%, n = 7, P = 0.2, TNP-ATP: -72 ±
4%, n=5, P< 0.05) (Figure 6C). In contrast, the number
of cells responding to ATP in rats injected with CFA chan-
ged the response to PPADS, but not to minocycline and
L-α-AA (minocycline: -5 ± 12%, n = 5, P = 0.2, L-α-AA: -
15 ± 12%, n= 3, P = 0.2, PPADS: -71 ± 7%, n= 4, P< 0.01).
Discussion
In the present study, we examined the contribution of
glial cells to central sensitization in the rat spinal dorsal
horn which is induced in neuropathic pain and inflam-
matory pain. We performed immunohistochemical stain-
ing of glial cells and imaging of neuronal excitation and
ATP-induced Ca2+ signaling. In rats subjected to PNI,
OX 42 immunoreactivity was markedly increased com-
pared to that in control rats. In rats injected with CFA,
GFAP immunoreactivity was increased slightly compared
to that in control rats. We showed for the first time that
neuronal excitation was augmented in both group of
treated rats compared to control rats. Minocycline,
SB203580 and TNP-ATP inhibited neuronal excitation
in rats subjected to PNI. L-α-AA, carbenoxolone and
SP600125 inhibited neuronal excitation in rats injected
with CFA. We also showed that the number of cells
showing inceased Ca2+ signaling in response to ATP was
augmented in rats subjected to PNI and the Ca2+ signal-
ing was inhibited by minocycline and TNP-ATP.
Morphological changes of glial cells by inflammatory and
neuropathic pain
In agreement with previous studies we showed that the
OX 42 immunoreactivity in the ipsilateral spinal dorsal
horn increases under the neuropathic pain [7,14], whereas
the increase in GFAP immunoreactivity in both group of
treated rats was slight. Although Raghavendra et al.
(2004) reported an increases of OX 42 immunostaining
and mRNAs for other markers of microglial activation in
the lumbar spinal cord after injection of CFA into the rat
hind paw [27], subsequent studies were unable to show an
Figure 5 Effect of astrocyte toxin, gap junction blocker and JNK
inhibitor on neuronal excitation. Effect of the astroglial toxin
L-alpha-aminoadipate (L-α-AA, 1 mM) (A), a gap junction blocker
carbenoxolone (100 μM) (B) and the JNK inhibitor SP600125 (10 μM)
(C) on neuronal excitation in control rats, rats injected with
complete Freund adjuvant (CFA), and rats subjected to peripheral
nerve injury (PNI). Data are expressed as % inhibition of the mean
intensity of optical response during the preincubation period.
*P< 0.05, **P< 0.01.
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lus [28]. In other inflammatory pain models, microglial ac-
tivation has been observed by immunohistochemistry for
OX 42. For example, the perisciatic administration ofzymosan, which is a model of sciatic inflammatory neur-
opathy, significantly increased OX 42 immunoreactivity in
the ipsilateral dorsal horn [28]. However, subcutaneous in-
jection of zymosan into the rat hind paw did not induce
robust morphological microglial activation [6].
Many studies have reported a slight increase in GFAP
immunoreactivity ~1 week after PNI and that it also
increases in the chronic period [29]. There are not many
studies showing changes in GFAP immunoreactivity in in-
flammatory pain models, however, after injection of CFA
into the rat hind paw, Raghavendra et al. (2004) reported
an increase in GFAP immunostaining in the lumbar spinal
cord [27], and Gao et al. (2010c) reported an increase in
JNK1 in astrocytes bilaterally [30]. Taken together, these
observations are consistent with the previous report. That
is, pain hypersensitivity in response to nerve injury, but
not to inflammation, induces a substantial morphologic
change in spinal cord microglia. In contrast, in inflamma-
tion, slight morphologic changes in astrocytes occur.
Hyperexcitability of optically-recorded neuronal
excitation by inflammatory and neuropathic pain
Central sensitization was originally described as an im-
mediate-onset, or activity- or use-dependent increase in
the excitability of nociceptive neurons in the dorsal horn
of the spinal cord via brief nociceptor input. After the
induction of central sensitization via a brief intense
nociceptor-conditioning stimulus, a mechanism known
as subliminal input (which is normally too weak to
evoke an action potential in the dorsal horn neurons)
begins to activate dorsal horn neurons as a result of
increased synaptic efficacy. Central sensitization in the
spinal dorsal horn is believed to be a mechanism for the
induction and maintenance of pain hypersensitivity
[1,2,22,23,31,32].
Voltage-sensitive dyes respond well to the cellular mem-
brane potential. Therefore, optical imaging with these dyes
has been used to assess neuronal membrane potential
changes and neuronal excitation [21-23]. In the present
study, we first showed that the optical responses evoked
by single-pulse stimulation to the dorsal root in spinal
slices from treated rats were stronger than that in slices
from control rats, indicating that excitability in the spinal
dorsal horn of treated rats was facilitated, and suggesting
that central sensitization in the spinal dorsal horn is a
mechanism for maintenance of pain hypersensitivity
under conditions of inflammation and nerve injury.
Contribution of micrglia to the hyperexcitability of
neuronal excitation under neuropathic pain
It has been reported that long-term potentiation (LTP),
which is a kind of synaptic plasticity and is lasting increase
of synaptic strength, in the spinal dorsal horn induced by
high-frequency conditioning stimulation (HFS) is inhibited
Figure 6 Ca2+ signals induced by puff-application of ATP. Ca2+
signals induced by puff-application of ATP. A, Representative
example of Ca2+ signals in the spinal dorsal horn of a rat subjected
to peripheral nerve injury (PNI) and treated with puff-application of
ATP. White dots in the left image indicate cells in the spinal dorsal
horn loaded with Fluo-4/AM during preapplication of ATP. The right
image shows the Ca2+ signal response to puff-application of ATP 10
s after application. B, Quantification of the number of cells showing
a Ca2+ signal response to ATP in control rats, rats injected with
complete Freund adjuvant (CFA), and rats subjected to PNI.
*P< 0.05, **P< 0.01 compared to control rats. C, The upper graph
indicates the effect of the microglial inhibitor minocycline (20 μM),
the specific P2X1,2,3,5 antagonist pyridoxal-phosphate-6-azophenyl-
2',4'-disulfonate (PPADS, 20 μM), the specific P2X1,2,3,4 antagonist
2',3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP, 1
μM) on Ca2+ signals in rats subjected to PNI and responding to ATP.
The lower graph indicates the effect of the microglial inhibitor
minocycline (20 μM), the astroglial toxin L-alpha-aminoadipate (L-α-
AA, 1 mM) and the specific P2X1,2,3,5 antagonist pyridoxal-
phosphate-6-azophenyl-2',4'-disulfonate (PPADS, 20 μM) on Ca2+
signals in rats subjected to CFA and responding to ATP. Data are
expressed as % of the decrease in the number of cells responding
to drug application. *P< 0.05, **P< 0.01.
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tamate transporter 1, which is predominantly expressed by
astrocytes, has also been shown to block HFS-induced
LTP and c-Fos expression [34]. It has also been reported
that the long-term facilitation of optically-recorded neur-
onal excitation with voltage-sensitive dye induced by low-
frequency conditioning stimulation or by ATP incubation
in the spinal cord slice is inhibited by blockage of glia-
related mechanisms [22,23].
In the present study, we first showed that neuronal exci-
tation in the spinal dorsal horn in rats subjected to PNI
was depressed by inhibition of microglia and p38 MAPK
and by an antagonist of the P2X4 receptor. It has been
reported that cells expressing P2X4 receptors are micro-
glia and acute pharmacologic blockade of P2X4 receptors
reverses established tactile allodynia induced by PNI [14].
PNI leads to activation of p38 MAPK in the spinal cord,
and acute pharmacologic inhibition of p38 MAPK in the
spinal cord suppresses tactile allodynia [30,35]. It has re-
cently been suggested that a release of brain-derived
neurotrophic factor from microglia via P2X4R-evoked
increases in Ca2+ and activation of p38 MAPK is a mech-
anism for pain hypersensitivity after PNI [20]. Our present
results suggest that the facilitation of neuronal excitation
in the spinal dorsal horn of rats subjected to PNI is
mediated by the activation of p38 MAPK and the P2X4 re-
ceptor in the microglia and that such microglia-related fa-
cilitation may be a mechanism for the maintenance of
pain hypersensitivity in rats subjected to PNI. However,
the specific inhibition of astroglial function by intrathecal
injection of fluorocitrate or L-α-AA, or JNK peptide in-
hibitor has been shown to attenuate pain hypersensitivity
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astrocyte is also important for neuropathic pain. However,
it should be emphasized that, as used in the majority of
previous studies, we used general glial inhibitors, such as
minocycline. Since the mechanism of action remains un-
certain, they may have other biological actions or actions
to neurons.
Contribution of astrocytes to the hyperexcitability of
neuronal excitation under inflammatory pain
In the present study, we first revealed that the neuronal
excitation in the spinal dorsal horn in rats injected with
CFA was depressed by inhibition of astrocytes and JNK
and by blocking of gap junctions. It has been reported that
bilateral activation of JNK in the spinal astrocytes is
increased by CFA injection to the rat hind paw, and that
mechanical allodynia induced by CFA injection is reversed
by pharmacologic blockade of JNK bilaterally [30].
Astrocytes are characterized by the formation of gap
junctions that connect them. Connnexin 43 is the major
gap junction protein in astrocytes [37]. Although there is
no direct evidence showing a contribution of spinal
astrocyte gap junctions to pain hypersensitivity in re-
sponse to CFA injection, some reports indicate a contri-
bution of gap junctions to pain. Hanstein et al. (2010)
reported that the intraperitoneal gap junction blocker
carbenoxolone reverses pain hypersensitivity induced by
submandibular CFA injection [38]. In addition, Spataro
et al. (2004) reported that intrathecal carbenoxolone
reverses the bilateral mechanical allodynia induced by
the perisciatic injection of zymosan, chronic constriction
injury, and intrathecal gp120 [24].
Our present results suggest that the facilitation of
neuronal excitation in the spinal dorsal horn of CFA-
injected rats is mediated by the activation of astrocyte
JNK and gap junctions, and that such astrocyte-related
facilitation may be a mechanism for the maintenance of
pain hypersensitivity in inflammatory pain in response
to CFA injection. However, the intrathecal administra-
tion of minocycline has been reported to attenuate
formalin-evoked second-phase flinching behaviour or
carrageenan-induced hyperalgesia [39]. In the CFA-
injected rats, significant increase of microglial markers
(Mac-1, TLR4 and CD14) at 4 and 14 days following in-
jection has been reported [27]. These studies suggest
that inflammatory pain is also induced by microglia-
related mechanisms. Immunohistochemical staining of
JNK and connexin will be necessary to identify these
mechanisms more directly.
Augmentation of Ca2+ signals evoked by puff-application
of ATP via P2X4 receptors under neuropathic pain
The measurement of intracellular Ca2+ concentration has
been used widely to analyze the excitability of glial cells[25,26], particularly in the culture. In the present study,
we used the spinal cord slice preparation for Ca2+ imaging
to examine glial excitability in the context of coexistence
with neurons. In the slice preparation, ATP can induce
Ca2+ influx not only in glial cells but also in neurons and
primary afferent terminals in the spinal dorsal horn [40].
The Ca2+ signals observed in the present study may repre-
sent a mixture of glial cells, neurons and afferent term-
inals. However, the Ca2+ signal in rats subjected to PNI
was largely inhibited by minocycline and a specific
P2X1,2,3,4 antagonist TNP-ATP (1 μM), but not by a
P2X1,2,3,5 antagonist PPADS (20 μM). Therefore, it is likely
that the increase in cells showing a Ca2+ response to ATP
in rats subjected to PNI in comparison to control and
CFA-injected rats reflect P2X4 receptors in spinal micro-
glia. Identification of glial cells in spinal cord slices will be
necessary to further clarify this.Conclusions
In the present study, we have shown that hyperexcitabil-
ity in the spinal dorsal horn under the condition of pain
hypersensitivity induced by nerve injury or inflammation
is mediated by microglia-related and astrocyte-related
mechanisms, respectively. Our results suggest that glia-
mediated central sensitization in the spinal dorsal horn
is a mechanism for pain hypersensitivity and that there
are distinct plastic changes in glia-neuron interactions in
different forms of persistent pain.
It should be emphasized that we used young rats in
the present study. It has been reported that the develop-
ment of glial responses and allodynia to nerve injury dif-
fers according to age in rats [41,42]. In addition, we
examined only a 1-week period after injury and inflam-
mation. It has been reported that astrocytes are activated
during the chronic period after PNI [35]. Therefore, it is
possible that the astrocyte-mediated hyperexcitability
observed in the present study might also occur during
the chronic period after PNI. Further investigations are
necessary to reveal the developmental changes.Methods
Animal models
All animal studies were undertaken according to protocols
approved by the university animal ethics committee in
University of Fukui on 20- to 30-day-old male and female
Wistar rats, weighting 45-70 g. For the PNI model, the left
spinal L5 nerve root was ligated under 2,2,2-tribromoetha-
nol anesthesia (0.2 g kg-1, intraperitoneally, Wako Pure
Chemical Industries). For the CFA (inflammatory) model,
50 μl CFA (Sigma-Aldrich) was injected into the left intra-
plantar hind paw. Mechanical allodynia was assessed by
determining foot withdrawal to 50% of mechanical thresh-
olds after mechanical plantar stimulation with von Frey
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paradigm [43].
Slice preparation
Rats were anaesthetized with diethyl ether. After lamin-
ectomy, the spinal cord was excised, and several trans-
verse slices (400-μm thick) with dorsal roots attached
were prepared from the lumbosacral enlargement (L4-6).
The rats were then killed with an over dose of ether.
Membrane potential imaging
Each slice was stained in a bath filled with the voltage-
sensitive absorption dye, RH-482 (0.1 mg ml-1, 20 min),
and set in a submersion-type chamber (0.2 ml) on an
inverted microscope (IMT-2, Olympus) equipped with a
150-W halogen lamp. Slices were perfused with Ringer so-
lution containing (in mM): 124 NaCl, 5 KCl, 1.2 KH2PO4,
1.3 MgSO4, 2.4 CaCl2, 26 NaHCO3, 0.2 thiourea, 0.2 as-
corbic acid, and 10 glucose (oxygenated with 95% O2 and
5% CO2) at room temperature (23 ± 2 °C). The change in
light absorption, at a wavelength of 700 ± 32 nm in a
0.83-mm2 area of the dorsal horn was recorded with an
imaging system (Deltalon 1700, Fuji Film) equipped with
128 × 128 pixel photo sensors at a frame rate of 0.6 ms.
The dorsal root was stimulated by a current pulse of 2
mA with a duration of 0.5 ms through a glass suction elec-
trode. Sixteen single pulses were administered at a con-
stant interval of 15 s. Starting at 10 ms before each
stimulus, the image sensor acquired 128 consecutive
frames of light-absorption images at a sampling interval of
0.6 ms. A reference frame, which was acquired immedi-
ately before each series of 128 frames, was subtracted
from the subsequent 128 frames. Sixteen series of such
difference images were averaged and stored. We deter-
mined the initial frame by averaging the first 15 frames of
the difference image and then subtracting this average
from each of the 128 frames of image data on a pixel-by-
pixel basis to eliminate the effects of noise in the reference
frame. The ratio image was then calculated by dividing the
image data by the reference frame.
Ca2+ imaging
Each slice was loaded for 45 min at room temperature
with 10 μM Fluo-4/AM in the presence of 0.01% Pluronic
F-127 (Molecular Probes). Slices were then washed thor-
oughly with Ringer solution, and set in a submersion-type
chamber (0.2 ml) on an inverted microscope (IX71, Olym-
pus). Confocal images of Fluo-4 fluorescence were cap-
tured at 1 frame s-1 with a CSU10 Nipkow spinning-disk
confocal microscope (Yokogawa Electric), equipped with
an EM CCD camera (iXON EM, Andor). Fluo-4 fluores-
cence was excited by light at 488 nm from a semicon-
ductor laser. ATP was puff- applied for 5 s at 20 s after
the start of recording.Immunohistochemistry
Rats were deeply anesthetized and perfused intracar-
dially with 0.01 M phosphate-buffered saline (PBS) fol-
lowed by 4% cold, buffered paraformaldehyde. The
spinal cord was then removed immediately, postfixed at
4 °C overnight in the same fixative and then cryopro-
tected in 20% sucrose in PBS (pH 7.4) for 48 h and sec-
tioned at 40-μm thickness. Nonspecific antibody binding
was inhibited by incubating the slices in 3% normal goat
serum. Slices were then incubated for 48 h at 4 °C with
antibody against OX42 (anti-OX 42, 1:400, Serotec), a
microglia marker, or with antibody against glial fibrillary
acidic protein (GFAP) (anti-GFAP, 1:400; Sigma-
Aldrich), an astrocyte marker. After incubation, tissue
sections were washed and incubated for 3 h at room
temperature with secondary antibody solution (anti-
rabbit IgG-conjugated Alexa Fluor 488, 1:400; Molecular
Probes). Immunofluorescence intensity measurements
were obtained with a digital camera (DP72, Olympus) on
a fluorescence microscope (AX80, Olympus). For the
image analysis, the free image analysis software ImageJ
1.40f (NIH) was used to measure the density of OX 42-
or GFAP-immuoreactivity. Quantitative assessment was
made by determining the immunofluorescence intensity
within a fixed area of the central substantia gelatinosa
(200 μm2), and the mean intensity of this area recorded.
This protocol was carried out on 3 L4-6 spinal sections
from each rat. The background fluorescence intensity of
each section was also determined and subtracted from
values obtained.
Statistical analysis
Results are expressed as means ± standard error of the
mean (SEM). The Student’s paired t-test was used to as-
sess statistical differences.
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